May 25, 09:07
AnnouncementsGlenmark Pharmaceuticals board recommends dividend
57% of moneycontrol users recommend buying Glenmark.
What's your call on Glenmark today?
Read 1 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3052.95||0.92||4382.95||2750.00||52,085.66|
|Dec' 15||Sep' 15||Jun' 15||Mar' 15|
|Public (FII + DII)||53.53||53.55||53.56||51.70|
Minda Industries Recommended on Feb 5th 2016
Recommended price 881.00 | Peak from reco 1249.00 41.77%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Glenmark is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 24,181.64 crore.
The company management includes Glenn Saldanha - Chairman & Managing Director, Rajesh Desai - Executive Director, Cherylann Pinto - Director - Corporate Affairs, D R Mehta - Non Executive Director, J F Ribeiro - Non Executive Director, Sridhar Gorthi - Non Executive Director, Brian W Tempest - Non Executive Director, Bernard Munos - Non Executive Director, B E Saldanha - Non Executive Director, Milind Sarwate - Additional Director, Sridhar Gorthi - Non Executive Director, Brian W Tempest - Non Executive Director, Bernard Munos - Non Executive Director, B E Saldanha - Non Executive Director, Milind Sarwate - Additional Director.
It is listed on the BSE with a BSE Code of 532296 and the NSE with an NSE Code of GLENMARK.
Its Registered office is at B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai,Maharashtra - 400026.
Their Registrars are Karvy Computershare Private Ltd.